Quantifying the extent of invasive carcinoma and margin status in partial mastectomy cases having a gross lesion: Is a defined tissue processing protocol needed?

American Journal of Clinical Pathology

Volumn 136, Issue 5, 2011, Pages 747-753

  Sneed, George M ^a   Duncan, Lisa D ^a  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

Breast carcinoma; Ductal carcinoma; Invasive carcinoma; Lobular carcinoma; Margin status; Partial mastectomy; Processing protocol

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST LOBULAR CARCINOMA; CANCER STAGING; CLINICAL PROTOCOL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; TISSUE MAPPING; TISSUE PREPARATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; QUALITY ASSURANCE, HEALTH CARE; SPECIMEN HANDLING;

EID: 80355125728     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPY4MI1RCWPTVR     Document Type: Article

References (36)

1. Holland R, Hendricks JH, Vebeek AL, et al. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet. 1990;335:519-522. (Pubitemid 20073065)
2. Holland R, Hendricks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol. 1994;11:181-192. (Pubitemid 24308078)
3. Grin A, Horne G, Ennis M, et al. Measuring extent of ductal carcinoma in situ in breast excision specimens. Arch Pathol Lab Med. 2009;133:31-37.
4. Lester SC, Bose S, Chen YY, et al. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast. Arch Pathol Lab Med. 2009;133:15-25.
5. Silverstein MJ, Poller D, Craig P, et al. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2005;201:586-597. (Pubitemid 41393082)
6. O'Sullivan MJ, Morrow M. Ductal carcinoma in situ: current management. Surg Clin North Am. 2007;87:333-351, viii. (Pubitemid 46693951)
7. Sigal-Zafrani B, Lewis J, Clough K, et al. Histological margin assessment for breast ductal carcinoma in situ: precision and implications. Mod Pathol. 2004;17:81-88. (Pubitemid 41656456)
8. Dillon MF, McDermott EW, O'Doherty A, et al. Factors affecting successful breast conservation for ductal carcinoma in situ. Ann Surg Oncol. 2007;14:1618-1628. (Pubitemid 46790985)
9. Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer. 2002;94:1917-1924. (Pubitemid 34270043)
10. Cheng L, Al-Kaisi NK, Gordon NH, et al. Relationship between the size and margin status of ductal carcinoma in situ of the breast and residual disease. J Natl Cancer Inst. 1997;89:1356-1360. (Pubitemid 27418026)
11. Silverstein MJ, Gierson ED, Colburn WJ, et al. Can intraductal breast carcinoma be excised completely by local excision: clinical and pathologic predictors. Cancer. 1994;73:2985-2989. (Pubitemid 24170772)
12. Dixon JM, Anderson TJ, Page DL, et al. Infiltrating lobular carcinoma of the breast. Histopathology. 1982;6:149-161. (Pubitemid 12150073)
13. Di Saverio S, Catena F, Santini D, et al. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Breast Cancer Res Treat. 2008;109:405-416. (Pubitemid 351692055)
14. Solin LJ, Fourquet A, Vicini FA, et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys. 2001;50:991-1002. (Pubitemid 32594839)
15. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340:1455-1461. (Pubitemid 29220544)
16. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001;19:2263-2271. (Pubitemid 32366979)
17. Fisher ER, Dignam J, Tan-Chiu, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight year update for protocol B-17: intraductal carcinoma. Cancer. 1999;86:429-438. (Pubitemid 29347405)
18. Chan KC, Knox WF, Sinha G, et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer. 2001;91:9-16. (Pubitemid 32052608)
19. Weng EY, Juillard GJ, Parker RG, et al. Outcomes and factors impacting local recurrence of ductal carcinoma in situ. Cancer. 2000;88:1643-1649. (Pubitemid 30183150)
20. Van Zee KJ, Liberman L, Samli B, et al. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age. Cancer. 1999;86:1757-1767. (Pubitemid 29513045)
21. Neuschatz AC, DiPetrillo T, Safaii H, et al. Margin width as a determinant of local control with and without radiation therapy for ductal carcinoma in situ (DCIS) of the breast. Int J Cancer. 2001;96:97-104.
22. Vicini FA, Lacerna MD, Goldstein NS, et al. Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 1997;39:627-635. (Pubitemid 27441429)
23. MacDonald HR, Silverstein MJU, Mabry H, et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005;190:521-525. (Pubitemid 41306068)
24. Asjoe FT, Altintas S, Huizing MT, et al. The value of Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis. Breast J. 2007;13:359-367. (Pubitemid 46985562)
25. Goldstein NS, Kestin L, Vicini F. Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy. Am J Surg Pathol. 1999;23:1340-1348. (Pubitemid 29517327)
26. Dadmanesh F, Xuemo F, Dastane A, et al. Comparative analysis of size estimation by mapping and counting number of blocks with ductal carcinoma it situ in breast excision specimens. Arch Pathol Lab Med. 2009;133:26-30.
27. Consensus conference on the classification of ductal carcinoma in situ. Hum Pathol. 1997;28:1221-1225.
28. Schnitt S, Wang H. Histologic sampling of grossly benign breast biopsies: how much is enough? Am J Surg Pathol. 1989;13:505-512. (Pubitemid 19149613)
29. Lester SC. Manual of Surgical Pathology. 2nd ed. Boston, MA: Elsevier Churchill Livingstone; 2006.
30. Rosai J. Rosai and Ackerman's Surgical Pathology. New York, NY: Mosby; 2004.
31. Lagios MD, Bennington JL. Protocol for the pathologic examination and tissue processing of the mammographically detected breast biopsy. Pathology (Phila). 1992;1:23-45.
32. Silverstein GF, Poller D, Craig P, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 1996;77:2267-2274. (Pubitemid 26162419)
33. Moatamed NA, Apple SK. Extensive sampling changes T-staging of infiltrating lobular carcinoma of breast: a comparative study of gross versus microscopic tumor sizes. Breast J. 2006;12:511-517. (Pubitemid 44690838)
34. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast: clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113-120. (Pubitemid 26002745)
35. Cristofanilli M, Gonzalez-Angulo A, Sneige N, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol. 2005;23:41-48. (Pubitemid 41702621)
36. du Toit RS, Locker AP, Ellis IO, et al. Invasive lobular carcinomas of the breast: the prognosis of histopathological subtypes. Br J Cancer. 1989;60:605-609. (Pubitemid 19251460)